image
Ultragenyx Pharmaceutical Inc. RARE
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 44.75
-6.07 %
$ 4.13 B
Market Cap
-7.05
P/E
BALANCE SHEET
1.49 B ASSETS
-3.52%
Growth Rates
1Year -3.52%
3Years -5.37%
5Years 15.69%
7Years 15.60%
10Years 37.97%
1.22 B LIABILITIES
1.90%
Growth Rates
1Year 1.90%
3Years 26.17%
5Years 61.50%
7Years 51.40%
10Years 62.38%
275 M EQUITY
-21.87%
Growth Rates
1Year -21.87%
3Years -37.98%
5Years -14.67%
7Years -7.46%
10Years 18.58%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Ultragenyx Pharmaceutical Inc.
image
Current Assets 732 M
Cash & Short-Term Investments 577 M
Receivables 73.4 M
Other Current Assets 81.6 M
Non-Current Assets 759 M
Long-Term Investments 200 M
PP&E 291 M
Other Non-Current Assets 268 M
Current Liabilities 280 M
Accounts Payable 42.1 M
Short-Term Debt 12.6 M
Other Current Liabilities 226 M
Non-Current Liabilities 935 M
Long-Term Debt 30.6 M
Other Non-Current Liabilities 905 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 213.6 132.9 307.6 713.5 433.6 113.4 100.5 161.1 93.6 24.3 7.4 86.2 10.6
Short Term Investments 363.6 614.8 432.6 488.0 321.6 346.3 134.0 219.0 343.4 163.2 46.0 0 0
Receivables 73.4 40.4 28.4 23.1 32.8 12.7 5.2 0 0 0 0 0 0.1
Inventory 34.0 26.8 16.2 13.0 11.5 7.1 0.8 0 0 0 0 0 0
Other Current Assets 47.6 68.9 71.7 57.6 51.4 42.9 29.2 21.5 13.2 11.9 3.7 0.3 0.2
Total Current Assets 732.2 883.9 856.6 1 295.3 851.0 522.4 244.5 498.1 450.2 187.5 55.2 86.4 11.0
PP&E 290.6 285.7 176.2 114.0 74.7 20.0 21.8 17.1 7.4 3.0 1.3 1.4 0.8
Intangible Assets 166.3 160.1 130.8 131.1 129.0 129.2 141.5 0 0 0 0 0 0
Goodwill 44.4 44.4 44.4 44.4 44.4 44.4 44.4 0 0 0 0 0 0
Long Term Investments 199.9 154.5 293.9 165.9 32.9 1.8 10.0 118.0 99.3 0 0 0 0
Other Long Term Assets 57.7 10.7 11.6 (24.5) (4.2) 3.5 3.4 (92.5) 2.7 7.4 3.1 0.5 0.4
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 1 491.0 1 545.4 1 522.4 1 759.6 1 135.5 719.6 490.8 540.6 559.6 198.0 59.6 88.3 12.1
LIABILITIES
Accounts Payable 42.1 43.3 17.1 12.9 12.9 12.3 8.9 5.4 2.9 4.9 1.4 1.2 0.3
Short Term Debt 12.6 23.6 22.1 18.0 14.5 0 0 0 0 0 0 0 0
Other Current Liabilities 225.7 192.9 134.5 140.9 76.0 62.5 56.1 54.9 25.0 7.7 4.5 2.0 0.7
Total Current Liabilities 280.4 261.2 181.4 189.6 103.3 74.7 71.0 60.3 27.9 12.5 5.9 3.2 1.0
Long Term Debt 30.6 19.8 382.7 39.3 29.8 0 0 0 0 0 0 0 0
Deferred Tax Income 30.1 31.7 33.3 33.3 33.3 31.2 31.2 0 0 0 0 0 0
Other Liabilities 874.5 880.3 1.0 335.7 315.4 4.8 5.1 6.4 0.6 0.5 3.6 0.8 0.5
Total Liabilities 1 215.6 1 193.0 599.8 605.2 481.7 110.7 107.3 66.7 28.5 13.0 9.5 4.0 1.5
EQUITY
Common Stock 82 K 70 K 69 K 67 K 58 K 51 K 44 K 41 K 39 K 32 K 4 K 3 K 3 K
Retained Earnings (3 387.7) (2 781.0) (2 073.6) (1 619.6) (1 433.0) (1 030.3) (832.7) (530.5) (284.7) (139.0) (74.8) (27.1) (8.2)
Other Accumulative Comprehensive Income/Loss 0.6 (6.6) (1.4) 0.7 (0.1) (0.6) (5.7) 0.9 (0.9) (0.2) 11 K (0.4) 40 K
Total Equity 275.4 352.5 922.6 1 154.4 653.8 608.9 383.5 474.0 531.1 184.9 50.1 84.3 10.6
Total Liabilities and Equity 1 491.0 1 545.4 1 522.4 1 759.6 1 135.5 719.6 490.8 540.6 559.6 198.0 59.6 88.3 12.1
SHARES OUTSTANDING
Common Shares Outstanding 73.5 69.9 67.8 60.8 56.6 49.8 42.5 39.6 36.8 28.8 29.1 23.1 23.1